UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children

Journal of allergy and clinical immunology, 2010-08, Vol.126 (2), p.256-262

2010

Volltextzugriff (PDF)

Risk scoring tool to predict respiratory syncytial virus hospitalisation in premature infants

Pediatric pulmonology, 2018-05, Vol.53 (5), p.605-612

2018

Volltextzugriff (PDF)

Interaction between healthcare professionals and parents is a key determinant of parental distress during childhood hospitalisation for respiratory syncytial virus infection (European RSV Outcomes Study [EROS])

Acta Paediatrica, 2018-05, Vol.107 (5), p.854-860

2018

Volltextzugriff (PDF)

Extrauterine growth restriction in very preterm infant: etiology, diagnosis, and 2-year follow-up

European journal of pediatrics, 2020-09, Vol.179 (9), p.1469-1479

2020

Volltextzugriff (PDF)

Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western Countries

Infectious diseases and therapy, 2016-09, Vol.5 (3), p.271-298

2016

Volltextzugriff (PDF)

Trends in survival among extremely-low-birth-weight infants (less than 1000 g) without significant bronchopulmonary dysplasia

BMC pediatrics, 2012-06, Vol.12 (1), p.63-63, Article 63

2012

Volltextzugriff (PDF)

Past, Present and Future Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children

Infectious diseases and therapy, 2018-03, Vol.7 (1), p.87-120

2018

Volltextzugriff (PDF)

Guidelines on CMV congenital infection

Journal of perinatal medicine, 2009-09, Vol.37 (5), p.433-445

2009

Volltextzugriff (PDF)

Long-Term Burden and Respiratory Effects of Respiratory Syncytial Virus Hospitalization in Preterm Infants-The SPRING Study

PloS one, 2015-05, Vol.10 (5), p.e0125422

2015

Volltextzugriff (PDF)

Opinion: The optimal use of risk factors to guide palivizumab prophylaxis against severe respiratory syncytial virus infection in moderate-to-late preterm infants

Frontiers in pediatrics, 2024, Vol.12, p.1343960-1343960

2024

Volltextzugriff (PDF)

Palivizumab Prophylaxis, Respiratory Syncytial Virus, and Subsequent Recurrent Wheezing

The Journal of pediatrics, 2007-07, Vol.151 (1), p.34-42.e1

2007

Volltextzugriff (PDF)

The effects of varying protein and energy intakes on the growth and body composition of very low birth weight infants

Nutrition journal, 2011-12, Vol.10 (1), p.140-140, Article 140

2011

Volltextzugriff (PDF)

Treatment and prevention of malaria in pregnancy and newborn

Journal of perinatal medicine, 2008-01, Vol.36 (1), p.15-29

2008

Volltextzugriff (PDF)

A predictive model for respiratory syncytial virus (RSV) hospitalisation of premature infants born at 33-35 weeks of gestational age, based on data from the Spanish FLIP Study

Respiratory research, 2008-12, Vol.9 (1), p.78-78, Article 78

2008

Volltextzugriff (PDF)

Impact of chorioamnionitis on exhaled nitric oxide and endotracheal aspirate levels of nitrites-nitrates and interleukin-8 in mechanically ventilated preterm neonates

Pediatric pulmonology, 2011-06, Vol.46 (6), p.595-603

2011

Volltextzugriff (PDF)

Case-control study of the risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born at a gestational age of 33-35 weeks in Spain

The Pediatric infectious disease journal, 2004-09, Vol.23 (9), p.815-820

2004

Volltextzugriff (PDF)

Effect of maternal clinical chorioamnionitis on neonatal morbidity in very-low birthweight infants: a case-control study

Journal of perinatal medicine, 2010-05, Vol.38 (3), p.269-273

2010

Volltextzugriff (PDF)

FLIP-2 Study: risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born in Spain at a gestational age of 32 to 35 weeks

The Pediatric infectious disease journal, 2008-09, Vol.27 (9), p.788-793

2008

Volltextzugriff (PDF)

RSV prevention in infancy and asthma in later life

The lancet respiratory medicine, 2018-07, Vol.6 (7), p.e31-e31

Carbonell-Estrany, Xavier

2018

Volltextzugriff (PDF)

Respiratory syncytial virus prophylaxis for children with chronic lung disease: have we got the criteria right?

Expert review of anti-infective therapy, 2019-04, Vol.17 (4), p.211-222

2019

Volltextzugriff (PDF)

Prioritising respiratory syncytial virus prevention in low-income and middle-income countries

The Lancet global health, 2023-05, Vol.11 (5), p.e655-e657

2023

Volltextzugriff (PDF)

Hospitalization rates for respiratory syncytial virus infection in premature infants born during two consecutive seasons

The Pediatric infectious disease journal, 2001-09, Vol.20 (9), p.874-879

2001

Volltextzugriff (PDF)

Impact of severe disease caused by respiratory syncytial virus in children living in developed countries

The Pediatric infectious disease journal, 2003-02, Vol.22 (2 Suppl), p.S13

2003

Volltextzugriff (PDF)

Accurately Assessing the Expected Impact of Universal First Respiratory Syncytial Virus (RSV) Season Immunization With Nirsevimab Against RSV-Related Outcomes and Costs Among All US Infants

The Journal of infectious diseases, 2023-05, Vol.227 (11), p.1333-1334

2023

Volltextzugriff (PDF)

Challenges in the prevention or treatment of RSV with emerging new agents in children from low- and middle-income countries

Expert review of anti-infective therapy, 2021-04, Vol.19 (4), p.419-441

2021

Volltextzugriff (PDF)

1 – 25 von 84

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(81)
Mit Volltextzugriff
(55)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(61)
Life Sciences & Biomedicine
(59)
Humans
(49)
Infant, Newborn
(44)
Pediatrics
(42)
Respiratory Syncytial Virus
(35)
Female
(33)
Infant, Premature
(31)
Risk Factors
(28)
Infectious Diseases
(26)
Gestational Age
(24)
Male
(23)
Biological And Medical Sciences
(22)
Infant
(21)
Medical Sciences
(21)
Hospitalization
(16)
Palivizumab
(16)
Obstetrics & Gynecology
(15)
Respiratory Syncytial Virus Infections - Prevention & Control
(15)
Hospitalization - Statistics & Numerical Data
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children

Risk scoring tool to predict respiratory syncytial virus hospitalisation in premature infants

Interaction between healthcare professionals and parents is a key determinant of parental distress during childhood hospitalisation for respiratory syncytial virus infection (European RSV Outcomes Study [EROS])

Extrauterine growth restriction in very preterm infant: etiology, diagnosis, and 2-year follow-up

Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western Countries

Trends in survival among extremely-low-birth-weight infants (less than 1000 g) without significant bronchopulmonary dysplasia

Past, Present and Future Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children

Guidelines on CMV congenital infection

Long-Term Burden and Respiratory Effects of Respiratory Syncytial Virus Hospitalization in Preterm Infants-The SPRING Study

Opinion: The optimal use of risk factors to guide palivizumab prophylaxis against severe respiratory syncytial virus infection in moderate-to-late preterm infants

Palivizumab Prophylaxis, Respiratory Syncytial Virus, and Subsequent Recurrent Wheezing

The effects of varying protein and energy intakes on the growth and body composition of very low birth weight infants

Treatment and prevention of malaria in pregnancy and newborn

A predictive model for respiratory syncytial virus (RSV) hospitalisation of premature infants born at 33-35 weeks of gestational age, based on data from the Spanish FLIP Study

Impact of chorioamnionitis on exhaled nitric oxide and endotracheal aspirate levels of nitrites-nitrates and interleukin-8 in mechanically ventilated preterm neonates

Case-control study of the risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born at a gestational age of 33-35 weeks in Spain

Effect of maternal clinical chorioamnionitis on neonatal morbidity in very-low birthweight infants: a case-control study

FLIP-2 Study: risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born in Spain at a gestational age of 32 to 35 weeks

RSV prevention in infancy and asthma in later life

Respiratory syncytial virus prophylaxis for children with chronic lung disease: have we got the criteria right?

Prioritising respiratory syncytial virus prevention in low-income and middle-income countries

Hospitalization rates for respiratory syncytial virus infection in premature infants born during two consecutive seasons

Impact of severe disease caused by respiratory syncytial virus in children living in developed countries

Accurately Assessing the Expected Impact of Universal First Respiratory Syncytial Virus (RSV) Season Immunization With Nirsevimab Against RSV-Related Outcomes and Costs Among All US Infants

Challenges in the prevention or treatment of RSV with emerging new agents in children from low- and middle-income countries

Suchergebnisse filtern